<DOC>
	<DOCNO>NCT02239120</DOCNO>
	<brief_summary>This trial enroll approximately 6,000 patient recent embolic stroke unknown source ( ESUS ) . Patients randomize dabigatran acetylsalicyclic acid ( ASA ) ( 1:1 ratio ) visit every three month . The study doctor may prescribe blind concomitant ASA pt coronary artery disease mandatory . All Adverse Events ( AEs ) , Serious Adverse Events ( SAEs ) , outcome event record . The trial conclude require number stroke event positively adjudicate estimated take 3 year ( include 2.5 year enrollment ) .</brief_summary>
	<brief_title>Dabigatran Etexilate Secondary Stroke Prevention Patients With Embolic Stroke Undetermined Source ( RE-SPECT ESUS )</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>Inclusion criterion : Ischemic stroke brain lesion visualize neuroimaging ( either brain Computed Tomography ( CT ) Magnetic Resonance Image ( MRI ) ) . The visualized stroke nonlacunar infarct , e.g . involve cortex &gt; 1.5 cm ( &gt; 2.0 cm measure MRI diffusionweighted image ) large diameter exclusively subcortical.Visualization CT usually require delayed image &gt; 2448 hour stroke onset . The index stroke must occur either 3 month randomization ( Modified Rankin Scale ( mRS ) &lt; =3 randomization ) 6 month randomization ( mRS &lt; =3 randomization ) select patient &gt; = 60 year plus least one additional risk factor recurrent stroke . Arterial image cervical plus TCD ultrasonography show extracranial intracranial atherosclerosis &gt; = 50 % luminal stenosis artery supply area acute ischemia . As evidenced cardiac monitoring &gt; = 20 hour automate rhythm detection , absence AF &gt; 6 minute duration ( within 20 hour period , either single episode cumulative time multiple episode ) . Further inclusion criterion apply . Exclusion criterion : Modified Rankin Scale &gt; =4 time randomization inability swallow medication . Major risk cardioembolic source embolism : ) intracardiac thrombus evidence transthoracic transesophageal echocardiography , b ) paroxysmal , persistent permanent AF , c ) atrial flutter , ) prosthetic cardiac valve ( mitral aortic , bioprosthetic mechanical ) , e ) atrial myxoma , f ) cardiac tumor , g ) moderate severe mitral stenosis , h ) recent ( &lt; 4weeks ) myocardial infarction , ) valvular vegetation , j ) infective endocarditis . Any indication require treatment anticoagulant per Investigator ` judgment . History atrial fibrillation ( unless due reversible cause hyperthyroidism binge drinking , permanently resolve ) . Other specific stroke etiology ( i.e . cerebral arteritis arterial dissection , migraine aura/vasospasm , drug abuse ) . Renal impairment estimate creatinine clearance ( calculate CockcroftGault equation ) &lt; 30mL/min screening , Investigator expect creatinine clearance likely drop 30mL/min course study . Further exclusion criterion apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>150 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>